Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 593-597, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sadler, W. A.
Right arrow Articles by Turner, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sadler, W. A.
Right arrow Articles by Turner, J. G.

Clinical Chemistry, Vol 42, 593-597, Copyright © 1996 by American Association for Clinical Chemistry

Influence of specimen carryover on sensitive thyrotropin (TSH) assays: is there a problem?

WA Sadler, LM Murray and JG Turner
Department of Nuclear Medicine, Christchurch Hospital, New Zealand.

A relatively slow transition has occurred from so-called 1st-generation thyrotropin (TSH) assays (e.g., RIAs) through 2nd-generation assays (e.g., IRMAs) to 3rd-generation assays (e.g., immunochemiluminometric assays). Analysis of data from a modified internal quality-control design, followed up by a computer simulation, showed that specimen carryover has minimal effect on 2nd-generation TSH assays. However, extension of the simulation to a 3rd-generation assay showed the possibility of substantial effects in the subnormal region. Carryover of 1:1250 (0.08%), for example, may reduce the theoretical 10-fold precision improvement claimed for 3rd-generation assays to nearer fourfold. Simulation results suggest maximum allowable specimen carryover of approximately 1:10,000 (approximately 0.01%) for 3rd- generation TSH assays. We suggest that when automated specimen handling is used in a TSH assay, a well-designed carryover experiment should become a routine part of reports that claim 3rd-generation (or better) performance characteristics.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
Q.-P. Qin, M. Christiansen, and K. Pettersson
Point-of-Care Time-resolved Immunofluorometric Assay for Human Pregnancy-associated Plasma Protein A: Use in First-Trimester Screening for Down Syndrome
Clin. Chem., March 1, 2002; 48(3): 473 - 483.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. Sotorrio, A. Quiros, and J. M. Izquierdo
New Immunoelectrochemiluminometric Assay to Measure Serum Thyrotropin,
Clin. Chem., December 1, 1997; 43(12): 2428 - 2430.
[Full Text]

Home page
 Clin. Chem.Home page
R. Sapin, F. Gasser, M. d'Herbomez, J. L. Wemeau, C. Ebert, and J. L. Schlienger
Elecsys(R) Thyrotropin (TSH) Assay Evaluated
Clin. Chem., March 1, 1997; 43(3): 545 - 547.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.